Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australia’s Pharma Industry Urges No Cuts In PBS Spending

This article was originally published in PharmAsia News

Executive Summary

The head of Medicines Australia, which represents the pharmaceutical industry, urged the government to keep funding for the Pharmaceutical Benefits Scheme as it is, at $7 billion a year. Will Delaat, a cancer survivor, made the appeal as the government considers making budget cuts in the face of a faltering economy. Delaat said the government should quantify the areas of health spending before deciding which health programs to cut. Until the government has that information, he said, "don't jeopardize the integrity of the PBS." (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts